Clinical Trial Update: Thrombolysis in Factor Xa-inhibitors Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial is evaluating thrombolysis in stroke patients who are taking Factor Xa inhibitors; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Drugs mentioned

• Apixaban (apixaban)
• Edoxaban (edoxaban)
• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Guri Hagberg | Conditions: Stroke, Stroke (in Patients With Atrial Fibrillation) | Phase 3 | Status: RECRUITING